62 web-programmer-developer-"St"-"UCL"-"St" Postdoctoral positions at KINGS COLLEGE LONDON
Sort by
Refine Your Search
-
from 1st January 2026 until 31 December 2028. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat to Support
-
development and pro and antisocial behaviours. We believe it is essential to investigate the determinants of typical development in order to understand variation in behaviour (or illness). About the role We
-
research themes in cardiac biology, having the specific aim to develop technologies for gene editing of cardiovascular inherited conditions. In particular, the post-holder will develop CRISPR/Cas9- and Prime
-
of Professor Katherine Brickell and Dr Rosalie Warnock, the PDRA will take on responsibilities for year-two of the 24-month Sensory Lives study. In year one (January-December 2025), the team developed playful
-
year (pro-rata) for professional development. This entitlement, from the Concordat to Support the Career Development of Researchers , applies to Postdocs, Research Assistants, Research and Teaching
-
of survivors of coercive control. This unique study has been co-developed with the Violence, Abuse and Mental Health Network’s (VAMHN) Lived Experience Action Group (LEAG) and aims to build a theoretical
-
year (pro-rata) for professional development. This entitlement, from the Concordat to Support the Career Development of Researchers , applies to Postdocs, Research Assistants, Research and Teaching
-
from 1st January 2026 until 31 December 2028. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat to Support
-
bacterial infections. About the role The bacterial pathogen Klebsiella pneumoniae (Kp) is a major antibiotic-resistant pathogen responsible for high levels of mortality worldwide. Development of novel
-
pathogen Klebsiella pneumoniae (Kp) is a major antibiotic-resistant pathogen responsible for high levels of mortality worldwide. Development of novel therapies and preventative vaccines is hampered by